|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Control of renal uric acid excretion and gout显示文摘 | Taniguchi A Kamatani N | 2008 | Curr Opin Rheumatol2008，20，2： | 1 |
| 2 | Platelet-activating factor, PAF acetylhydrolase,and anaphylaxis显示文摘 | Okamoto H Kamatani N | 2008 | N Engl J Med2008，358，1： | 1 |
| 3 | A retrospective study of the rela-tionship between serum urate level and recurrent attacks of gouty ar-thritis:evidence for reduction of recurrent gouty arthritis with antihy-peruricemic therapy显示文摘 | Shoji A Yamanaka H Kamatani N | 2004 | Arthritis Rheum2004，51，3： | 1 |
| 4 | Differential binding avidities of human IgM for staphylococcal protein A derive from specific germ-line VH3 gene usage显示文摘 | HAKODA M KAMATANI N HAVASHIMOTOKURUMADA S | 1996 | J Immunol1996，157，： | 1 |
| 5 | Familial juvenile hyperuricemic nephropathy:detection of mutations in the uromodulin gene in five Japanese families显示文摘 | Kudo E Kamatani N Tezuka O | 2004 | Kidney Int2004，65，5： | 1 |
| 6 | A genomewide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians显示文摘 | Kamatani Y Wattanapokayakit S Ochi H Kawaguchi T Takahashi A Hosono N Kubo M Tsunoda T Kamatani N Kumada H Puseenam A Sura T Daigo Y Chayama K Chantratita W Nakamura Y Matsuda K | 2009 | Nat Genet2009，41，5： | 1 |
| 7 | Generation and molecular characterization of monoclonal IgG4 rheumatoid factor from a patient with rheumatoid arthritis 显示文摘 | Hakoda M Kamatani N Taniguchi A | 1997 | Ann Rheum Dis1997，56，： | 1 |
| 8 | PhaseⅡdose-response clinical trial using febuxostat(TMX-67),a nov-eltype xanthine oxidase/xanthine dehydrogenase inhibi-tor,for gout and hyperuricemia显示文摘 | Kamatani N Fujimori S H Hada T | 2003 | Arthritis Rheum2003，48，19： | 1 |
| 9 | Analysis of the genotypes for aldehyde dehydrogenasa 2 in Japanese patients with primary gout显示文摘 | Yamanaka H Kamatani N Hakoda M | | 0，，： | 1 |
| 10 | A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis:evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy显示文摘 | Shoji A Yamanaka H Kamatani N | 2004 | Arthritis Rheum2004，51，： | 1 |
| 11 | The molecular mechanism of osteoclastogenesis in rheumatoid arthritis 显示文摘 | UDAGAWA N KOTAKE S KAMATANI N | 2002 | Arthritis Res2002，4，5： | 1 |
| 12 | Rituximab for rheumatoid arthritis 显示文摘 | Okamoto H Kamatani N | 2004 | N Engl J Med2004，351，： | 1 |
| 13 | The molecularmechanism of osteoclastogenesis in rheumatoid arthritis显示文摘 | Udagawa N Kotake S Kamatani N | 2002 | Arthritis Res2002，4，5： | 1 |
| 14 | Age and origin of the G774A mutation in SLC22A12 causing renal hypourieemia in Japanese 显示文摘 | Ichida K Hosoyamada M Kamatani N | 2008 | Clin Genet2008，74，3： | 1 |
| 15 | A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis:evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy显示文摘 | Shoji A Yamanaka H Kamatani N | 2004 | Arthritis Rheum2004，51，3： | 1 |
| 16 | An allopurinol- controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study 显示文摘 | KAMATANI N FUJIMORI S HADA T | 2011 | J Clin Rheumatol2011，17，42： | 1 |
| 17 | Platelet acti4ating factor, PAF acetylhydrolase, and anaphylaxis 显示文摘 | OKAMOTO H KAMATANI N | 2008 | N Engl J Med2008，358，1： | 1 |
| 18 | Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japa- nese显示文摘 | Ichida K Hosoyamada M Kamatani N | 2008 | Clin Genet2008，74，3： | 1 |
| 19 | Clinicalaspects of gouty patients in Taiwan显示文摘 | Chen CH Kamatani N Nishicka K | 1989 | Adv Exp Med Biol1989，253，1： | 1 |
| 20 | Sjrgren' s syndrome in one of two sisters with idiopathic renal hypouricemia 显示文摘 | Yamanaka H Tanignchi A Kamatani N | 1994 | Intern Med1994，33，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员